Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Nocturia peptide trials
9 selected ClinicalTrials.gov records carrying the official condition label Nocturia. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
9 selected records.
1 profiles.
2009–2022 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 25 selected PubMed records and 38 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Nocturia unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT00902655
PeptideScanner retained ClinicalTrials.gov record NCT00902655 at 2026-11-16T01:33:21.554Z. Its registry update date was 2009-05-15, and PeptideScanner's reviewed identity mapping was desmopressin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- May 15, 2009
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT01184859
PeptideScanner retained ClinicalTrials.gov record NCT01184859 at 2026-11-16T01:33:21.554Z. Its registry update date was 2012-05-25, and PeptideScanner's reviewed identity mapping was desmopressin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- May 25, 2012
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT01223937
PeptideScanner retained ClinicalTrials.gov record NCT01223937 at 2026-11-16T01:33:21.554Z. Its registry update date was 2015-10-15, and PeptideScanner's reviewed identity mapping was desmopressin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- October 15, 2015
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Desmopressin · 2022-12-15
ClinicalTrials.gov record NCT01439997
Completed at the retained observation.
Open attributed record →Desmopressin · 2022-03-02
ClinicalTrials.gov record NCT03201419
Completed at the retained observation.
Open attributed record →Desmopressin · 2019-09-11
ClinicalTrials.gov record NCT02904759
Completed at the retained observation.
Open attributed record →Desmopressin · 2019-09-11
ClinicalTrials.gov record NCT02905682
Completed at the retained observation.
Open attributed record →Desmopressin · 2017-07-11
ClinicalTrials.gov record NCT01552343
Completed at the retained observation.
Open attributed record →Desmopressin · 2015-10-15
ClinicalTrials.gov record NCT01223937
Completed at the retained observation.
Open attributed record →Desmopressin · 2015-10-15
ClinicalTrials.gov record NCT01262456
Completed at the retained observation.
Open attributed record →Desmopressin · 2012-05-25
ClinicalTrials.gov record NCT01184859
Completed at the retained observation.
Open attributed record →Desmopressin · 2009-05-15
ClinicalTrials.gov record NCT00902655
Completed at the retained observation.
Open attributed record →